En‐Chi Hsu

National Health Research Institutes — Taiwan

Medicine · Health Sciences

25h-index2.4kcitations74works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(22), Peptidase Inhibition and Analysis(8), Cell Adhesion Molecules Research(6), Ferroptosis and cancer prognosis(5), Cancer, Lipids, and Metabolism(5)

Publications74 total

Supplementary Figure S1 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S4 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S2 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S5 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Data from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Table 1 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S3 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
Cancer Research·2025· 1 cited
Extracellular Vesicles in Serum Carry Trop2 Protein as a Potential Molecular Indicator in Prostate Cancer
Journal of Extracellular Biology·2025· 1 citedOpen Access
Circulating extracellular vesicles in serum carry Trop2 marker for prostate cancer liquid biopsy and clinical care
2025Open Access
An enzymatic-independent function of palmitoyl hydrolase in cohesin loading onto chromosome
Nucleic Acids Research·2025· 1 citedOpen Access
P4.04D.05 Family History is an Independent Predictor of Lung Cancer Detection in Women in a Predominantly Caucasian Screening Cohort
Journal of Thoracic Oncology·2024
Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer
Cancer Research·2024
Abstract 5968: CDC7 is a targetable regulator of advanced prostate cancer
Cancer Research·2024
Abstract 6574: UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas
Cancer Research·2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Cell Reports Medicine·2024· 25 citedOpen Access
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Scientific Reports·2024· 9 citedOpen Access
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
British Journal of Cancer·2023· 6 citedOpen Access
Data from Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies
2023Open Access
Supplementary Figures 1-7 from Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Tanya Stoyanova(34), Merve Aslan(21), James D. Brooks(21), Shiqin Liu(17), Sharon J. Pitteri(16), Meghan A. Rice(15), Michelle Shen(14), Fernando Jose Garcia-Marques(13), Rosalie Nolley(13), Abel Bermudez(12), Samuel K. Kulp(9), Ali Ghoochani(8), Donna M. Peehl(7), Christian A. Kunder(7), Holly M. Nguyen(6), Eva Corey(6), Ching-Shih Chen(6), Michael A. Liss(6), Alifiani B. Hartono(5), Chiyuan Amy Zhang(4)